86 related articles for article (PubMed ID: 31565099)
1. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer.
Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y
Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099
[TBL] [Abstract][Full Text] [Related]
2. The kinesin-14 family motor protein KIFC2 promotes prostate cancer progression by regulating p65.
Liu X; Lin Y; Long W; Yi R; Zhang X; Xie C; Jin N; Qiu Z; Liu X
J Biol Chem; 2023 Nov; 299(11):105253. PubMed ID: 37716704
[TBL] [Abstract][Full Text] [Related]
3. FOXM1/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response.
Fang K; Gong M; Liu D; Liang S; Li Y; Sang W; Zhu R
Heliyon; 2023 Dec; 9(12):e22734. PubMed ID: 38125441
[TBL] [Abstract][Full Text] [Related]
4. KIF20A silence inhibits the migration, invasion and proliferation of non-small cell lung cancer and regulates the JNK pathway.
Xie F; He C; Gao S; Yang Z; Li L; Qiao L; Fang L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):135-142. PubMed ID: 31557334
[TBL] [Abstract][Full Text] [Related]
5. An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer.
Das R; Sjöström M; Shrestha R; Yogodzinski C; Egusa EA; Chesner LN; Chen WS; Chou J; Dang DK; Swinderman JT; Ge A; Hua JT; Kabir S; Quigley DA; Small EJ; Ashworth A; Feng FY; Gilbert LA
Nat Commun; 2021 Jul; 12(1):4601. PubMed ID: 34326322
[TBL] [Abstract][Full Text] [Related]
6. Role of a Kinesin Motor in Cancer Cell Mechanics.
Mandal K; Pogoda K; Nandi S; Mathieu S; Kasri A; Klein E; Radvanyi F; Goud B; Janmey PA; Manneville JB
Nano Lett; 2019 Nov; 19(11):7691-7702. PubMed ID: 31565944
[TBL] [Abstract][Full Text] [Related]
7. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.
Klee EW; Bondar OP; Goodmanson MK; Dyer RB; Erdogan S; Bergstralh EJ; Bergen HR; Sebo TJ; Klee GG
Clin Chem; 2012 Mar; 58(3):599-609. PubMed ID: 22247499
[TBL] [Abstract][Full Text] [Related]
8. [Bioinformatics-based analysis of the effect of general Transcription Factor IIH on prognosis of Prostate cancer].
Li JC; Zhu XJ; Ye JH; Tan ZH; Cai SH; Deng YL; Chen J; Tian WC; Luo DH; Zhong WD
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1410-1417. PubMed ID: 38644292
[No Abstract] [Full Text] [Related]
9. GLIS1, Correlated with Immune Infiltrates, Is a Potential Prognostic Biomarker in Prostate Cancer.
Peng Q; Xie T; Wang Y; Ho VW; Teoh JY; Chiu PK; Ng CF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203661
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of CELSR3 indicates a poor prognostic factor for Prostate Cancer.
Chen X; Ma Q; Liu Y; Li H; Liu Z; Zhang Z; Niu Y; Shang Z
J Cancer; 2021; 12(4):1115-1124. PubMed ID: 33442409
[No Abstract] [Full Text] [Related]
11. Retraction: KIF20A silence inhibits the migration, invasion and proliferation of non-small cell lung cancer and regulates the JNK pathway.
Clin Exp Pharmacol Physiol; 2021 Jan; 48(1):157. PubMed ID: 38019015
[No Abstract] [Full Text] [Related]
12. KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway.
Xiong M; Zhuang K; Luo Y; Lai Q; Luo X; Fang Y; Zhang Y; Li A; Liu S
Aging (Albany NY); 2019 Dec; 11(24):11905-11921. PubMed ID: 31841120
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of KIF2A and KIF20A expression in human cancer: A systematic review and meta-analysis.
Li X; Shu K; Wang Z; Ding D
Medicine (Baltimore); 2019 Nov; 98(46):e18040. PubMed ID: 31725680
[TBL] [Abstract][Full Text] [Related]
14. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer.
Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 modulates docetaxel resistance in prostate cancer by regulating KIF20A.
Yu H; Xu Z; Guo M; Wang W; Zhang W; Liang S; Xu Z; Ye J; Zhu G; Zhang C; Lin J
Cancer Cell Int; 2020 Nov; 20(1):545. PubMed ID: 33292277
[TBL] [Abstract][Full Text] [Related]
16. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C
Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240
[TBL] [Abstract][Full Text] [Related]
17. The SUN2-nesprin-2 LINC complex and KIF20A function in the Golgi dispersal.
Hieda M; Matsumoto T; Isobe M; Kurono S; Yuka K; Kametaka S; Wang JY; Chi YH; Kameda K; Kimura H; Matsuura N; Matsuura S
Sci Rep; 2021 Mar; 11(1):5358. PubMed ID: 33686165
[TBL] [Abstract][Full Text] [Related]
18. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Gillessen S; Bossi A; Davis ID; de Bono J; Fizazi K; James ND; Mottet N; Shore N; Small E; Smith M; Sweeney CJ; Tombal B; Antonarakis ES; Aparicio AM; Armstrong AJ; Attard G; Beer TM; Beltran H; Bjartell A; Blanchard P; Briganti A; Bristow RG; Bulbul M; Caffo O; Castellano D; Castro E; Cheng HH; Chi KN; Chowdhury S; Clarke CS; Clarke N; Daugaard G; De Santis M; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fonteyne V; Fossati N; Frydenberg M; George D; Gleave M; Gravis G; Halabi S; Heinrich D; Herrmann K; Higano C; Hofman MS; Horvath LG; Hussain M; Jereczek-Fossa BA; Jones R; Kanesvaran R; Kellokumpu-Lehtinen PL; Khauli RB; Klotz L; Kramer G; Leibowitz R; Logothetis C; Mahal B; Maluf F; Mateo J; Matheson D; Mehra N; Merseburger A; Morgans AK; Morris MJ; Mrabti H; Mukherji D; Murphy DG; Murthy V; Nguyen PL; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Pezaro CJ; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin MA; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Sharifi N; Skoneczna I; Soule H; Spratt DE; Srinivas S; Sternberg CN; Steuber T; Suzuki H; Sydes MR; Taplin ME; Tilki D; Türkeri L; Turco F; Uemura H; Uemura H; Ürün Y; Vale CL; van Oort I; Vapiwala N; Walz J; Yamoah K; Ye D; Yu EY; Zapatero A; Zilli T; Omlin A
Eur J Cancer; 2023 May; 185():178-215. PubMed ID: 37003085
[TBL] [Abstract][Full Text] [Related]
20. Expression, regulating mechanism and therapeutic target of KIF20A in multiple cancer.
Jin Z; Peng F; Zhang C; Tao S; Xu D; Zhu Z
Heliyon; 2023 Feb; 9(2):e13195. PubMed ID: 36798768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
